Skip to main content
. 2017 Oct 19;12(10):e0186554. doi: 10.1371/journal.pone.0186554

Fig 2. End-of-trial changes in ACR in diacerein and placebo participants stratified by baseline ACR ≥300 or < 300 mg/g.

Fig 2

Interaction of time and group (P = 0.006).